Cresco Labs Inc. (CRLBF) Accounts Payables (2019 - 2026)

Cresco Labs (CRLBF) has reported Accounts Payables for 8 consecutive years, with $16.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Accounts Payables fell 4.0% year-over-year to $16.3 million; the trailing twelve-month figure through Jun 2026 stood at $16.3 million (down 4.0% YoY), and the FY2025 full-year result was $16.5 million, up 21.16% from the prior year.
• Accounts Payables climbed to $16.3 million in Q2 2026 per CRLBF's latest filing, from $14.2 million in the prior quarter.
• Across five years, Accounts Payables topped out at $37.0 million in Q2 2022 and bottomed at $13.7 million in Q4 2024.
• Historically, Accounts Payables has averaged $21.3 million across 5 years, with a median of $19.0 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Accounts Payables sank 50.52% in 2024, then advanced 21.16% in 2025.
• Over 5 years, Accounts Payables stood at $28.1 million in 2022, then decreased by 1.8% to $27.6 million in 2023, then tumbled by 50.52% to $13.7 million in 2024, then increased by 21.16% to $16.5 million in 2025, then fell by 1.39% to $16.3 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $16.3 million, $14.2 million, and $16.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.